Fred Hassan
CIK 1110744 · Chairman and CEO · last filed 2026-06-24
Fred Hassan is a Chairman and CEO who has filed 86 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for BBIO, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$5.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $14.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.34M
10
86
$5.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 29,879 | $85.55 | $2.56M | $273.4K | 7 | 2026-06-24 |
| PGEN | Director | 1,243,239 | $5.53 | $6.88M | $998.1K | 14 | 2026-03-16 |
| COCP | Director | 1,383,009 | $0.93 | $1.29M | $0 | 4 | 2026-01-13 |
| EYPT | Director | — | $11.96 | — | $0 | 3 | 2026-01-06 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | Director | 0 | $199.92 | $0 | $0 | 5 | 2023-06-16 |
| AMGN | Director | 9,191 | $393.10 | $3.61M | $501.6K | 7 | 2020-05-07 |
| PRECIGEN, INC. (XON) Delisted | Director | 32,358 | — | — | $200.3K | 6 | 2019-03-26 |
| WARNER MEDIA, LLC (TWX) Delisted | Director | 0 | — | — | $1.01M | 22 | 2018-06-18 |
| AVON PRODUCTS INC (AVP) Delisted | Director | 49,079 | — | — | $0 | 8 | 2012-05-07 |
| MRK | Chairman and CEO | 0 | $131.82 | $0 | $2.01M | 8 | 2009-11-04 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | BBIO | Grant (A) | +3,990 | $0 | EDGAR |
| 2026-03-16 | PGEN | Exer (M) | +71,839 | $0 | EDGAR |
| 2026-03-12 | PGEN | Grant (A) | +17,948 | $63.0K | EDGAR |
| 2026-01-13 | COCP | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2025-10-30 | COCP | Grant (A) | +359,713 | $500.0K | EDGAR |
| 2025-06-24 | BBIO | Grant (A) | +6,589 | $0 | EDGAR |
| 2025-03-17 | PGEN | Mixed | +123,618 | $63.0K | EDGAR |
| 2025-01-07 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2024-10-11 | COCP | Grant (A) | +8,067 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.